A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives-Reference-Cited by-同舟云学术

A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives

Published:2019-01-09 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

do Amaral Daniel Nascimento,Lategahn Jonas^ORCID,Fokoue Harold Hilarion^ORCID,da Silva Eduardo Miguez Bastos,Sant’Anna Carlos Mauricio R.,Rauh Daniel,Barreiro Eliezer J.,Laufer Stefan,Lima Lidia Moreira

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-36846-7.pdf

Reference53 articles.

1. Cohen, P. & Alessi, D. R. Kinase drug discovery–what’s next in the field? ACS Chem. Biol. 8, 96–104 (2013).

2. Müller, S., Chaikuad, A., Gray, N. S. & Knapp, S. The ins and outs of selective kinase inhibitor development. Nat. Chem. Biol. 11, 818–821 (2015).

3. Knapp, S. & Sundström, M. Recently targeted kinases and their inhibitors - The path to clinical trials. Curr. Opin. Pharmacol. 17, 58–63 (2014).

4. Fabbro, D. 25 Years of Small Molecular Weight Kinase Inhibitors: Potentials and Limitations. Mol. Pharmacol. 10, 766–775 (2015).

5. Ferguson, F. M. & Gray, N. S. Kinase inhibitors: the road ahead. Nat. Rev. Drug Discov. 17, 353–377 (2018).

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, preparation and biological evaluation of new Rociletinib-inspired analogs as irreversible EGFR inhibitors to treat non-small-cell-lung cancer;Bioorganic & Medicinal Chemistry;2024-09

2. Design, Synthesis, and Anti-Tumor Activity Evaluation In Vitro of 4,6,7–Trisubstituted Quinazoline Derivatives Containing Acrylamide Group;Russian Journal of Bioorganic Chemistry;2024-04

3. 30 Years of Kinase Inhibitors: A Historical Overview and some Brazilian Contributions;Journal of the Brazilian Chemical Society;2024

4. LASSBio Chemical Library Diversity and FLT3 New Ligand Identification;Journal of the Brazilian Chemical Society;2024

5. Research Trends and Hot Spots of Allopregnanolone Research in the Last 20 Years: A Bibliometric Analysis;Drug Design, Development and Therapy;2023-11